Publications by authors named "Inmaculada Bando"

Claim this Profile
,
, a Gene Potentially Implicated in Familial Colorectal Cancer Type X.
Lorena Martín-Morales, Pilar Garre, Víctor Lorca, Marta Cazorla, Patricia Llovet, Inmaculada Bando

Cancer Prev Res (Phila)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
Javier Sastre, Virginia de la Orden, Antonio Martínez, Inmaculada Bando, Milagros Balbín

Clin Colorectal Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
Elena Elez, Carles Pericay, Manuel Valladares-Ayerbes, Inmaculada Bando, Maria Jose Safont

Br J Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
Lorena Martin-Morales, Paula Rofes, Eduardo Diaz-Rubio, Patricia Llovet, Victor Lorca, Inmaculada Bando

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy.
Patricia Llovet, Javier Sastre, Julián Sanz Ortega, Inmaculada Bando, Milagros Ferrer

Mol Diagn Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.
Pilar Garre, Lorena Martín, Inmaculada Bando, Alicia Tosar, Patricia Llovet

Fam Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative study.
Eduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, Javier Sastre, Margarita Reboredo, Inmaculada Bando

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of KRAS p.G13D mutation in patients with metastatic colorectal cancer treated with cetuximab.
Pablo Gajate, Javier Sastre, Inmaculada Bando, Teresa Alonso, Lourdes Cillero

Clin Colorectal Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of KRAS new predictive marker in a clinical laboratory.
Inmaculada Bando, Lourdes Cillero, Julián Sanz-Ortega, Patricia Llovet, Paula Pescador

Clin Transl Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous antioxidant defence system in rat liver following mercury chloride oral intoxication.
Inmaculada Bando, María Isabel Sánchez Reus, David Andrés, María Cascales

J Biochem Mol Toxicol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between expression of HSP70 and metallothionein and oxidative stress during mercury chloride induced acute liver injury in rats.
Isabel Sánchez Reus, Inmaculada Bando, David Andrés, María Cascales

J Biochem Mol Toxicol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis